Photocarcinogenesis and Susceptibility to UV Radiation in the v-Ha-ras Transgenic Tg.AC Mouse  by Trempus, Carol S. et al.
Photocarcinogenesis and Susceptibility to UV Radiation in the
v-Ha-ras Transgenic Tg.AC Mouse
Carol S. Trempus, Joel F. Mahler,* Honnavara N. Ananthaswamy,† Susan M. Loughlin,† John E. French, and
Raymond W. Tennant
Laboratories of Environmental Carcinogenesis and Mutagenesis and *Experimental Pathology, National Institute of Environmental Health Sciences, Research
Triangle Park, North Carolina, U.S.A.; †The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
The v-Ha-ras transgenic Tg.AC mouse line has proven to
be a useful model for the study of chemical carcinogenic
potential. We undertook experiments designed to study
the effect of the physical carcinogen, UV radiation, on
tumorigenesis in this mouse strain. Following a total of
three exposures on alternating days to a radiation source
covering a cumulative UVR exposure range of 2.6–
42.6 kJ per m2, squamous papillomas developed by
4 wk after initial exposure in a dose-dependent manner.
Malignancies developed within 18–30 wk following the
initial UVR exposure and were all diagnosed as squamous
cell carcinoma or spindle cell tumors. In contrast to other
mouse stains used in photocarcinogenesis studies, few
p53 mutations were found in Tg.AC malignancies upon
Skin cancer is one of the most common forms of cancer inhumans, with µ900,000 new cases of nonmelanoma cancersdiagnosed yearly (Parker et al, 1996; Black et al, 1997). Skincancers are, most likely, the result of complex interactionsbetween host risk factors and environmental exposure to
UV radiation and chemicals. One of the most common genetic lesions
in nonmelanoma skin cancer involves mutations in the p53 gene
(Nataraj et al, 1995). Brash et al (1991) demonstrated that the majority
of squamous cell carcinomas (SCC) contain ‘‘signature’’ UV mutations
in the p53 gene; i.e., C→T or CC→TT transitions. Subsequently,
Ziegler et al (1994) showed that UV-induced p53 mutations are in the
precursor lesion to SCC, actinic keratosis. It has also been shown that
p53 mutations have been detected in UV-induced tumors in the
mouse, and that these mutations demonstrate a ‘‘UV signature’’ (Kress
et al, 1992; Kanjilal et al, 1993). In addition, experimental evidence is
accumulating that p53 mutations are an early event in UV-mediated
skin carcinogenesis (Berg et al, 1996; Ananthaswamy et al, 1997; Black
et al, 1997), in contrast to other cancers where p53 mutations are more
likely a late event and contribute to progression (Kemp et al, 1993;
Black et al, 1997)
Much of our knowledge of multistage carcinogenesis has been
derived from mouse models, which have shown that aberrations
in oncogenes and tumor supressor genes cooperate in neoplastic
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polymerase chain reaction-single stranded conforma-
tional polymorphism analysis of exons 4–8 followed by
sequencing of suspicious bands; however, all tumors
analyzed by in situ hybridization expressed the v-Ha-
ras transgene. Immunohistochemical analysis of UVR-
exposed skin taken 24 h after the last of three exposures
(13.1 kJ per m2 total UVR) showed expression of p53
in hair follicles and in interfollicular epidermis, which
indicates that the gene was functional. Thus, although
there are some differences between the Tg.AC and other
mouse models, these results suggest that the Tg.AC
mouse may be a useful model for the study of acute
exposure photocarcinogenesis. Key words: papilloma/p53/
skin cancer. J Invest Dermatol 111:445–451, 1998
development (Yuspa et al, 1994). Mouse models have been used
extensively to study photocarcinogenesis and have proven to be
reasonably relevant to human skin cancer with respect to p53 mutations
and pathogenesis. The Tg.AC transgenic mouse model provides a
reporter phenotype of rapid induction of benign squamous papillomas.
The Tg.AC line, originally developed to study embryonic hematopo-
iesis, carries an estimated four tandem copies inserted into chromosome
11 of a construct of a fetal ζ-globin promoter fused to a v-Ha-ras
structural gene on an FVB/N background (Leder et al, 1990; Cannon
et al, 1997). One founder line was discovered to develop squamous
papillomas in response to bite-inflicted wounds (Leder et al, 1990).
Subsequently, it has been shown that the Tg.AC mouse is sensitive
to specific chemical agents, including tumor promoters [e.g., 12-
tetradecanoylphorbol-13-acetate (TPA)] (Leder et al, 1990; Spalding
et al, 1993), chemical carcinogens (Tennant and Spalding, 1996), and
full-thickness surgical wounding (Cannon et al, 1997). Expression of
the v-Ha-ras transgene has been shown to be associated with the
proliferative compartment in papilloma precursors and fully peduncu-
lated papillomas (Hansen and Tennant, 1994a); however, the transgene
is not expressed in normal, nontumor bearing epidermis (Hansen and
Tennant, 1994a). In addition, transgene expression has been shown in
all Tg.AC cutaneous malignancies as well as spontaneously arising
neoplasms (Cardiff et al, 1993; Wright et al, 1995; Hansen et al, 1996).
This indicates that rapid tumor development in this strain occurs only
upon induction of transgene expression. Cytogenetic analysis of skin
malignancies has revealed no consistent chromosomal abnormalities in
tumors taken from TPA-treated Tg.AC mice (French et al, 1994), and
no mutations have been found in endogenous c-Ha-ras at codons 12,
13, 59, or 61 in any tumor analyzed (Owens et al, 1995; Hansen
et al, 1996).
Because the Tg.AC mouse exhibits a rapid response to chemicals in
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Table I. Exposure range of UV radiation administered to
Tg.AC and FVB/N mice
Cumulative
exposure UVA UVB UVC Total
Group (min)a (kJ per m2) (kJ per m2) (kJ per m2) (kJ per m2)
1 50 17.10 26.40 0.150 43.6
2 25 8.55 13.20 0.075 21.8
3 15 5.13 7.92 0.045 13.1
4 7.5 2.57 3.96 0.023 6.6
5 3.0 1.03 1.58 0.008 2.6
aUV radiation was administered to the shaved dorsal surface of Tg.AC and FVB/N
mice over a total of three exposures, with UVA at 0.57 mW per cm2, UVB at 0.88 mW
per cm2, and UVC at 0.005 mW per cm2.
a highly selective fashion, the line represents a useful model for
carcinogenicity bioassays. In view of this responsiveness to chemicals,
we undertook a series of experiments designed to evaluate the response
of the Tg.AC mouse to UV radiation. The results presented here
demonstrate the potential value of the Tg.AC mouse line as a model for
studying the biologic and molecular mechanisms of photocarcinogenesis
based upon the induced papilloma phenotype.
MATERIALS AND METHODS
Animals Homozygous female Tg.AC mice, which contain a ζ-globin pro-
moter fused to a v-Ha-ras structural gene and linked to an SV40 polyadenylation/
splice sequence (Leder et al, 1990), and nontransgenic FVB/N mice (parental
strain) were obtained from Taconic Farms (Germantown, NY) at µ4 wk of
age. Animals were maintained in our animal facility and given Purina Pico
Chow no. 5058 (Barnes, Durham, NC) and water ad libitum, and kept on a
12 h light/dark cycle. All animal procedures were done in accordance with
American Association of Laboratory Animal Care and NIEHS guidelines for
the minimization and prevention of pain.
UV radiation source A bank of four 40 W FS4OT12 (Westinghouse,
Bloomfield, NJ) fluorescent sunlamps was used, with the radiation source
µ18 cm from the backs of the mice. UV emissions were measured using an
Oriel Spectrograph combined with a Compaq PC and InstaSpecII program.
Intensity was measured with IL 1400 A combined with photodetectors for
UVA and UVB radiation. The lamps emitted UVC (0.33%) at 0.005 mW per
cm2, UVB (60.36%) at 0.88 mW per cm2, and UVA (39.32%) at 0.57 mW per
cm2, with a total output of 1.46 mW per cm2. The lamps were aged 60 h prior
to the initial use in order to ensure a uniform emission of UVR during
animal exposures.
UVR exposure regime Female Tg.AC and FVB/N mice at µ20 wk of age
had the dorsal skin surface shaved with electric clippers prior to the first UV
exposure, and were shaved as needed for subsequent exposures. Five mice per
cage were placed in a large polycarbonate cage with no bedding and no cover.
The unrestrained mice were exposed every other day (M, W, F) for a total of
three exposures. In the first experiment, mice received cumulative exposures
of 43.6 or 21.8 kJ UVR per m2 for groups 1 and 2, respectively. In the second
experiment, mice received 13.1, 6.5, or 2.6 kJ UVR per m2 for groups 1, 2,
and 3, respectively. Ten mice per group were used in all experiments. Exposures
are summarized in Table I. The numbers of papillomas were recorded weekly
for 20 wk, and mice were held for observation of malignancies. Papillomas
were counted once they reached µ1 mm in size and were readily detectable
by touch.
Immunohistochemical detection of expression of p53 expression Skin
sections from UVR-exposed mice were removed 24 h after the last UVR
exposure (total cumulative exposure of 13.1 kJ per m2 administered over three
5 min exposures), fixed in 10% neutral buffered formalin, paraffin embedded,
and 4 µm serial sections cut onto Superfrost Plus microscope slides (Fisher
Scientific, Norcross, GA). Tissues were deparaffinized and rehydrated to
1 3 automation buffer (Biomeda, Foster City, CA), then subjected to microwave
heating (700 W) in 0.01 M citrate buffer, pH 6, for two 5 min cycles, followed
by slow cooling to room temperature. Slides were blocked [1% milk, 1%
bovine serum albumen, 5% normal goat serum (Vector, Burlingame, CA), in
1 3 automation buffer] and incubated overnight with an anti-mouse p53
antibody (pCM5, Vector) at a 1:500 dilution. Negative control slides were
incubated in rabbit IgG (Vector), also prepared at a 1:500 dilution. A Super
Sensitive detection kit (BioGenex Laboratories, San Ramon, CA) with diamino-
Table II. Synthetic oligonucleotide primers used to amplify
murine p53 for PCR-SSCP and sequence analysis of benign
and malignant tumor tissue from UV-exposed Tg.AC mice











benzidine as substrate (Sigma, St Louis, MO) was used for signal detection.
Tissues were counterstained with Harris Hematoxylin (Sigma).
In situ hybridization Normal skin, papillomas, and malignancies were removed
from UV-exposed mice, trimmed free of fat, and fixed overnight in either
4% paraformaldehyde or 10% neutral buffered formalin. Following paraffin
embedding, 4 µm serial sections were cut onto SuperFrost Plus microscope
slides (Fisher Scientific) for in situ hybridization analysis of v-Ha-ras transgene
expression as described previously (Hansen and Tennant, 1994a, b), using sense
and anti-sense riboprobes prepared from the SV40 region of the transgene con-
struct.
DNA extraction Frozen skin or tumors were homogenized in a lysis solution
(150 mM NaCl, 10 mM Tris-HCL, pH 8.0, 5 mM ethylenediamine tetraacetic
acid, 1% sodium dodecyl sulfate) containing 200 µg Proteinase K per ml and
200 µg Rnase per ml. The lysates were heated at 65°C for 15 min and then
incubated at 37°C overnight. After addition of NaCl to a final concentration
of 250 mM, DNA was extracted first with phenol, then with phenol:chloro-
form:isoamyl alcohol (25:24:1), and finally precipitated with two volumes of
cold 100% ethanol. The DNA was dried and dissolved in TE (10 mM Tris-
HCL, pH 8.0, 1 mM ethylenediamine tetraacetic acid, pH 8.0) buffer.
Polymerase chain reaction-single stranded conformational polymorph-
ism (PCR-SSCP) analysis of exons 4–8 of murine p53 Genomic DNA
were amplified using intron-exon primers specific for each of exons 4–8 of the
mouse p53 gene (Table II). Each PCR mixture (25 µl) consisted of 180 ng
DNA, 10 mM Tris-HCL (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.001%
gelatin, 75 mM each dATP, dCTP, dGTP, and dTTP, 2.5 mCi [α32P]dCTP,
200 nM of each upstream and downstream primer, and 0.75 U Amplitaq
(Perkin-Elmer, Foster City, CA). Amplification was as follows: samples were
denatured at 94°C for 4 min, followed by two cycles of 1 min each of 94°C,
65°C, and 72°C, then five cycles for 1 min each at 94°C, 60°C, and 72°C.
This was followed by 35 cycles for 1 min each at 94°C, 55°C, and 72°C, with
a final extension at 72°C for 15 min. The PCR products were heated at 94°C
for 5 min, quick cooled on ice, and separated by gel electrophoresis using an
MDE ultrahigh-resolution gel at 6 W for 16 h. The gel was dried and exposed
to autoradiography film. Extreme precaution was taken to prevent contamination
of PCR reactions, which included isolation of tissue samples and PCR reactions,
use of blank PCR controls without DNA templates, and inclusion of normal
mouse skin DNA in every PCR run. PCR-SSCP analysis was performed twice
to confirm the presence or absence of aberrant p53 bands.
Nucleotide sequencing Shifted (mutant) bands were excised from dried
SSCP gels and the DNA eluted in 100 µl of TE buffer by heating to 80°C for
30 min. The DNA was reamplified by PCR and the product treated with
Exonuclease I and Shrimp alkaline phosphatase at 37°C for 15 min, followed
by heating at 80°C for 15 min. The samples were directly sequenced using the
Thermo Sequence radiolabeled terminator cycle sequencing kit (Amersham,
Cleveland, OH) according to the manufacturer’s direction. In addition, DNA
from SSCP-positive tumors were amplified by PCR and directly sequenced to
confirm the p53 mutations in tumors. Normal mouse skin DNA was amplified
by PCR and sequenced to rule out PCR-generated mutations.
RESULTS
Papilloma response in UV-exposed Tg.AC and FVB/N mice
The Tg.AC line is unique among transgenic mouse models that show
skin phenotypes in that the transgene is not constitutively expressed
(Hansen and Tennant, 1994a; Hansen et al, 1996) and papillomas only
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Figure 1. UV-induced papillomagenesis in v-Ha-ras Tg.AC mice. Tg.AC
mice were exposed to UV radiation over a total of three separate occasions in
a 1 wk period and papilloma development followed for 20 wk after the initial
exposure. The data shown are the average weekly papilloma response for UVR-
exposed Tg.AC mice. Female FVB/N mice were exposed concomitantly with
Tg.AC mice at all exposure levels. Most animals developed no papillomas over
the course of the experiment (data not shown).
Table III. Summary of malignancy development in UVR-
exposed Tg.AC mice
UVR exposure No. of mice with confirmed Time of
(kJ per m2) malignancies (%) SCCa SCTb appearance (wk)
43.6 5/9 (55%) 4c 2 18–30
21.8 6/10 (60%) 6c 1 23–30
aSquamous cell carcinoma.
bSpindle cell tumor.
cOne mouse in each of the two exposure groups developed two malignancies, both of
which were removed at the time of necropsy.
occur upon exposure to specific chemicals (Hansen et al, 1995; Tennant
et al, 1996) or physical wounding (Cannon et al, 1997). In view of the
rapid induction of papillomas by chemicals, we were interested in
investigating the response of this mouse to UV radiation. At all
tumorigenic exposures of UV radiation, papillomas (about 1 mm) were
apparent by 4 wk following the initial exposure of Tg.AC mice (Fig 1).
A dose response occurred, from zero papilloma development at
2.6 kJ per m2 up to a maximum of 15.1 6 5.4 tumors per mouse at
the highest exposure of 43.6 kJ per m2. Papilloma multiplicity increased
from week 5 to week 10, but showed a slight decrease by week 20 in
the mice receiving the highest UV exposure (Fig 1). The apparent
change in multiplicity may be explained by animal deaths and tumor
loss from regression and/or removal by the animal.
Of the age-matched FVB/N background strain mice exposed
concurrently with the Tg.AC mice, only one mouse of 10 exposed
developed a papilloma at 43.6 kJ per m2 (data not shown). There was
no tumor development in any other UVR-exposed FVB/N group.
Cutaneous papillomas on UV-exposed Tg.AC mice progressed
to malignancy High dose (21.8 and 43.6 kJ per m2, respectively)
UVR-exposed Tg.AC and FVB/N were held beyond 20 wk to follow
any progression of benign papillomas to malignancy. Results are
summarized in Table III. A total of five of nine papilloma-bearing
mice had at least one cutaneous papilloma progress to malignancy at
the highest cumulative exposure group (one mouse had two lesions),
Figure 2. Photomicrographic representation of malignant tumor types
found in UV-exposed Tg.AC mice. UVR-exposed mice were observed for
malignant progression of cutaneous papillomas. (A) SCC; (B) SCT. Scale
bar: 0.2 mm.
four of which were diagnosed as SCC and two as spindle cell tumors
(SCT). Of these six tumors, four were removed at 25 wk following
initial exposure or earlier (range of 18–25 wk) and two were removed
at 30 wk. Six of 10 papilloma-bearing mice had papilloma progression
to malignancy in the 21.8 kJ per m2 exposure group (one mouse had
two lesions). Of these seven tumors, six were diagnosed as SCC and
one as a SCT. In addition, three of the seven malignancies were
removed at either 23 or 24 wk post-initial irradiation and four were
removed after 30 wk.
Tumor diagnosis was based on histologic criteria. SCC (Fig 2A)
were endophytic tumors that exhibited varying degrees of keratinocytic
differentiation. The more well-differentiated carcinomas were predom-
inately composed of cohesive sheets and ribbons of neoplastic ker-
atinocytes. In less differentiated tumors, keratinocytic areas were
intermingled with more individualized and elongated spindle cells
identical to those comprising SCT. Spindle cell tumors (Fig 2B) were
poorly circumscribed growths that diffusely infiltrated the dermis and
were composed of individualized elongated cells haphazardly arranged
in sworls and bundles. No foci of keratinocytic differentiation were
detectable in these tumors.
Malignancies in UV-irradiated Tg.AC mice express the v-Ha-
ras transgene in a pattern similar to tumors arising from
treatment with TPA Because the majority of TPA-induced cutane-
ous malignancies analyzed to date overexpress the ras transgene (Hansen
et al, 1996), we tested the hypothesis that the ras transgene would be
similarly overexpressed in UV-induced malignancies. In situ hybridiza-
tion analysis for ras transgene expression was performed on all malig-
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Figure 3. Detection of v-Ha-ras transgene
expression by in situ hybridization in a
malignancy containing both SCC and
SCT regions removed from a UV-
exposed Tg.AC mouse. Hematoxylin and
eosin stained sections are shown for (A) the
spindle region and (D) the SCC region of the
tumor. In situ hybridization was performed
with transgene specific anti-sense (B, E) and
negative control sense (C, F) riboprobes to
localize transgene expression in 10% neutral
buffered formalin fixed serial sections of the
tumor. Part (B) shows a dark field view of
transgene expression in the spindle portion of
the tumor, with the sense control pictured in
(C). Part (E) shows a dark field view of
specific transgene expression in the SCC
region, with the sense negative control shown
in (F) to demonstrate probe specificity. Scale
bar: 0.4 mm.
nancies removed from UVR-exposed animals (13 in all). Pictured in
Fig 3 is in situ hybridization detection of ras transgene expression in a
malignancy that had a region of well-differentiated SCC blending into
anaplastic spindle cells, which we selected as representative of both
types of tumors (SCC and SCT) we typically find in Tg.AC mice.
Figure 3(A) shows an hematoxylin and eosin stain of the spindle
portion of the tumor, and Fig 3(D) shows an hematoxylin and eosin
stain of the keratinocytic region of the tumor. As described previously
(Hansen et al, 1996), transgene expression was scattered randomly
throughout the tumor mass in the spindle portion of the tumor, shown
by hybridization of the transgene-specific anti-sense riboprobe in
Fig 3(B). In the keratinocytic region of the tumor, transgene expression
is clearly localized to the neoplastic epithelial cells and not to the
stroma (Fig 3E). Figures 3(C) and 3(F) show the sense riboprobe in
a serial section for the spindle and SCC regions, respectively, to
demonstrate the specificity of the assay. No cross-reactivity with
endogenous c-Ha-ras is expected with the probes used in these assays
because the probes are prepared exclusively from the nonendogenous
(SV40) region of the transgene construct.
UV-induced Tg.AC tumors harbor few p53 mutations p53
mutations are often observed in both human (Brash et al, 1991; Ziegler
et al, 1996) and murine (Kress et al, 1992; Kanjilal et al, 1993; Nataraj
et al, 1995) UVR-induced tumors. Thus, we were interested in
examining the status of the p53 gene in tumors collected from UV-
exposed Tg.AC mice. In addition, the malignancies developed about
10–15 wk earlier than what is generally observed with TPA-induction
in Tg.AC mice (unpublished observation), suggesting that the relatively
early progression to malignancy was possibly enhanced by UV-induced
mutations in the p53 gene. PCR-SSCP analysis, however, did not
reveal any mutations in exons 4–8 except in two tumors, which
displayed aberrant bands in exon 8 (Fig 4A). Normal, unexposed
Tg.AC skin (lanes 1 and 2) was compared with papillomas (lanes 3–9)
and malignancies (lanes 10–12) taken from UVR-exposed Tg.AC
mice. In addition, nontumorous skin adjacent to a malignancy (SCC)
removed from the same animal (lanes 13 and 14, respectively) were
analyzed for p53 mobility shifts, as well as DNA from skin, papilloma,
and malignancy from another UV-exposed animal (lanes 15–17). We
also looked at ulcerated areas and normal adjacent skin from UV-
exposed FVB/N mice (normal-appearing skin, lanes 18 and 20;
ulcerated tissues, lanes 19 and 21).
Of the tissues analyzed, only one papilloma (lane 7) gave a definite
mobility shift (see arrow) as compared with normal skin. Another
papilloma (lane 9) gave a suspicious banding pattern (see arrows). The
shifted bands from these two samples were excised from the SSCP gel
and subjected to sequence analysis of p53 exons 4–7 as described in
Materials and Methods. A C→T transition in codon 275 of exon 8,
which is a typical UV ‘‘signature’’ p53 mutation (Fig 5B), was found
in the shifted band from the papilloma in lane 7; however, the suspicious
band from the papilloma in lane 9 yielded wild-type p53 sequence.
UVR-induced expression of p53 in UVR exposed Tg.AC mice
Due to the lack of p53 mutations in tumors from UVR-exposed
Tg.AC mice, we were interested in determining whether the p53 gene
in transgenic Tg.AC responds to UVR. It is known that UVR induces
a transient upregulation of wild-type p53 expression that is probably
in response to DNA damage (Hall et al, 1993; Li et al, 1996).
Therefore, we examined UVR-exposed Tg.AC skin taken 24 h
after the last of three exposures by immunohistochemical analysis to
determine if p53 expression was upregulated. Figure 5(A) shows
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Figure 4. PCR-SSCP and sequence analysis for mutations in exons 4–
8 of the p53 gene, using genomic DNA extracted from UV-exposed
normal skin and tumor tissue removed from Tg.AC and FVB/N
mice. To determine if p53 mutations played a role in UVR-induced tumor
development, genomic DNA from UV-exposed tumor tissues were subjected
first to PCR-SSCP analysis (A) to visualize any mobility shifts of tumors
harboring p53 mutations. Mutant bands were then directly sequenced using
p53-specific primers (B). (A) Normal, unexposed Tg.AC skin (lanes 1 and 2);
papillomas from UV-exposed Tg.AC mice (lanes 3–9); malignancies (primarily
SCC) from UV-exposed Tg.AC mice (lanes 10–12); nontumor bearing skin
and malignancy (SCC) from a UV-exposed Tg.AC mouse (lanes 13 and 14,
respectively); nontumor bearing skin, papilloma, and malignancy (SCC) from
a UV-exposed Tg.AC mouse (lanes 15–17, respectively); nontumor bearing
skin (lanes 18 and 20); and ulcerated tissue from UV-exposed FVB/N mice
(lanes 19 and 21). (B) p53 sequence analysis of exon 8 for wild-type DNA and
mutant bands excised from lane 7 (A, papilloma; see arrows). Suspicious bands
shown by arrows in lane 9 (A) were also excised and sequenced, but mutations
were not detected.
normal, nonexposed Tg.AC following p53 immunohistochemistry. No
positive nuclei were observed in the epidermal or dermal compartments.
In contrast, UVR-exposed skin (Fig 5B) had positive nuclei clearly
evident in the basal cells of the interfollicular epidermis (arrow) and in
follicular cells, largely localized to the bulb region of the follicle
(arrowhead).
DISCUSSION
The v-Ha-ras Tg.AC mouse line has been shown to identify chemical
carcinogens (Hansen et al, 1995; Tennant et al, 1996), and papillomas
develop in response to full-thickness wounding (Cannon et al, 1997).
We have found that when 15–20 wk old mice are used in experimental
protocols, palpable tumors are detectable by 25 d after initial treatment,
and that skin tumors will develop in response to as few as four
applications of 2.5 µg TPA (Albert et al, 1996). We reasoned that if
the Tg.AC mouse was sensitive to UVR, skin tumors would develop
rapidly and in response to relatively few exposures.
Three exposures at various UVR intensities resulted in a dose-
dependent squamous papilloma response by 4 wk after the first exposure
of 20 wk old mice. Of the papilloma-bearing mice, about 60% went
on to develop at least one malignancy, all of which were SCC or
anaplastic spindle tumors. FVB/N nontransgenic background strain
exposed to UV concurrently with Tg.AC mice initially demonstrated
a similar response to UVR to the Tg.AC mice, in that there
was extensive hyperplasia, keratinization, and inflammation (data not
shown). In most FVB/N, however, these responses resolved after
Figure 5. Expression of p53 in UVR-exposed, Tg.AC skin 24 h after
the last of three exposures. Tg.AC mice were exposed to UVR three times
(cumulative UVR exposure of 13.1 kJ per m2) and skins collected 24 h after
the last exposure. Immunohistochemical analysis of p53 was performed on non-
UVR exposed skin (A) and UVR-exposed skin (B). p53-positive nuclei were
evident in UVR exposed skin in the basal epidermis (arrow) and in the bulb
region of hair follicles (arrowhead). Scale bar: 0.17 mm.
exposure stopped and the mice did not develop papillomas. We
therefore hypothesize that, as with chemical carcinogens that induce
papilloma development in Tg.AC mice, UVR-mediated papillomagen-
esis primarily occurs due to induction of expression of the v-Ha-ras
transgene. Indeed, all papillomas and malignancies express the ras
transgene as analyzed by in situ hybridization.
Because the tumors generated in this study were induced by UVR,
we were interested in the status of the p53 gene, as there is a substantial
body of evidence linking UVR-specific mutations in the p53 gene to
actinic keratosis (Ziegler et al, 1994), SCC, and basal cell carcinoma
in humans (Brash et al, 1991; Ziegler et al, 1993, 1994), and premalignant
lesions (Berg et al, 1996; Ananthaswamy et al, 1997) and SCC (Nataraj
et al, 1995) in UVR-exposed mice. In this study, PCR-SSCP revealed
only one tumor, a papilloma, as having a potential mutation, which
was subsequently confirmed by sequence analysis as a C→T transition
in codon 275 of exon 5. Because no histology was performed on this
tumor, we cannot rule out the possibility that it was actually a carcinoma
in situ rather than a benign squamous papilloma; however, for most of
the tumors analyzed, p53 does not appear to be a target for UVR-
induced tumorigenesis in the Tg.AC mouse.
The lack of p53 mutations may reflect the difference between acute
and chronic UVR exposure. In rodent models for UVR-induced skin
cancer, the incidence of malignancy and latency is dependent upon
the UVR exposure spectrum, intensity, and length of exposure. Berg
et al (1996) observed p53-expressing preneoplastic foci in SKH-1 mice
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following 17 and 30 d of suberythemal UVR exposure. Although
direct comparisons of UVR emissions cannot be made between our
lamps and those used by Berg et al (1996), their 17 d exposure protocol
yielded roughly the same cumulative exposure as our 25 min group
(22 vs 21.8 kJ per m2, respectively). In addition, their 30 cumulative
total of 39 kJ per m2 corresponds to our highest exposure group
(43 kJ per m2), so although we administered roughly the same total
amount of UVR, the amount of UVR per exposure and the timing
of exposure varied significantly. Others have also found evidence of
early incidence of p53 mutations, but only after several weeks of
chronic UVB exposure (Ananthaswamy et al, 1997). Taken together,
these studies would seem to indicate that in mice, chronic exposure is
necessary to acquire the genetic alterations commonly thought to drive
UVR-mediated tumorigenesis.
In addition, it has been shown that the time course of UVR-induced
tumor development is affected by the exposure protocol (Forbes et al,
1981). Skh:HR mice receiving the same weekly cumulative dose of
UVR (5760 J per m2) under different exposure regimens (exposed
either 1, 3, or 5 d a week) showed a differential tumor latency (Forbes
et al, 1981). Low level exposure spread out over 5 d weekly resulted
in a more rapid time to tumor development than one high level
exposure per week.
In our studies, the fact that the similarly exposed FVB/N mice did
not develop papillomas further implies that the mice did not receive
exposure in a manner consistent with efficient targeting of the p53
gene. Therefore, we feel that the acute exposure regimen employed
in these studies was sufficient to induce transgene expression and
allowed for transgene-mediated tumorigenesis in the absence of UVR-
induced p53 mutations. It would be of interest to chronically expose
Tg.AC mice to suberythemal doses of UVR to determine if p53 would
be targeted under those conditions. We hypothesize that the absence
of p53 mutations found in this study is most likely a consequence of
the acute UVR exposure regimen employed.
It has been shown that UVR exposure can induce a transient
upregulation of p53 expression in keratinocytes as early as 4 h after
UVR exposure, which usually resolves to basal levels by 72 h post-
irradiation (Hall et al, 1993; Berg et al, 1996; Li et al, 1996). This
upregulation of expression is generally believed to be of wild-type
rather than mutated p53 (Hall et al, 1993; Berg et al, 1996; Li et al,
1996), although evidence of p53 mutations has been found in
chronically irradiated preneoplastic murine skin (Berg et al, 1996;
Ananthaswamy et al, 1997). It is also believed that this transient
upregulation of p53 is primarily due to the DNA-repair function
attributed to p53 (Li et al, 1996). We have shown a similar increase of
p53 expression in the hair follicles and interfollicular epidermis of
Tg.AC skin after UVR exposure. That this expression is transient is
illustrated by the fact that there is no evidence of p53 positive nuclei
in UVR-exposed skin analyzed 5 d after the last exposure (data not
shown). Although this is not an unexpected finding, the upregulation
of p53 expression following UVR exposure demonstrates that the
mouse is responding to UVR in a manner consistent not only with
other mouse strains but also with the human skin response (Hall
et al, 1993).
The lamps used in these studies emitted a small amount of UVC
radiation (0.33%) between 275 and 280 nm. Because UVC has been
shown to efficiently damage DNA (Black et al, 1997), we were
concerned that even this small amount could contribute significantly
to tumor development. We can rule out this possibility for two reasons,
however. First, action spectra developed for various UV wavelengths
has shown that there is very little difference in the biologic response
between 275 and 280 nm (de Gruijl et al, 1983; IARC, 1992; Black
et al, 1997). Second, Campbell et al (1993) showed that UVA, UVB,
and UVC penetrate the epidermis differentially, with the effects of
UVC on p53 expression limited to the uppermost layers of the skin.
Immunohistochemistry for p53 expression following acute UVR
exposure in the Tg.AC mice has shown that p53 positivity is localized
to the basal epidermis and the hair follicles, consistent with UVA
and UVB exposure. Therefore, these results suggest that the UVC
component was not a significant factor in in vivo experiments.
Recent work in our laboratory has demonstrated that the induction
of ras transgene expression is mediated through transcriptional activation
of the ζ-globin promoter in both cutaneous lesions (Cannon et al,
1997) and spontaneous erythroleukemias that arise in the Tg.AC mouse
(Trempus et al, 1998). In addition, specific sequences of the transgene
construct have been shown to be hypomethylated and the appearance
of hypomethylation is consistent with the temporal induction of
transgene expression (Cannon et al, 1998). This provides us with
evidence that induction of transgene expression is not mediated by
upstream flanking sequences as a result of its insertion into chromosome
11, but rather is dependent upon activation of the promoter sequences
of the transgene itself. Overexpression of the transgene is thought to
then drive proliferation and clonal expansion of these cells, resulting
in not only cutaneous lesions (Hansen and Tennant, 1994a; Hansen
et al, 1995), but also spontaneously developing malignancies commonly
found in the Tg.AC mouse (Cardiff et al, 1993; Hansen et al, 1996).
UVR exposure under the conditions used in these studies resulted in
a papilloma response that is similar to that observed with application
of TPA or other chemicals (Leder et al, 1990; Spalding et al, 1993) and
wounding (Cannon et al, 1997), in that relatively few treatments
resulted in papilloma development within a 4–5 wk time frame.
Because there were no UVR-signature mutations in either the p53
gene or the endogenous c-Ha-ras at codons 12, 13, and 61 (Hansen
et al, 1996), we think that these three modes of tumorigenesis act via
a common mechanism in these mice, although to date we have no
experimental evidence for the precise signaling pathways that are
responsible for transgene activation. We hypothesize, however, that
activation of transgene expression not only results in stimulation of
cellular proliferation that drives subsequent neoplastic development
(Hansen et al, 1995), but also stimulates a positive feedback loop that
serves to maintain transgene expression (Cannon et al, 1997), which
offers some explanation as to why the transgene continues to be
expressed once the promotional signal has been removed.
In summary, we have given evidence that the Tg.AC mouse is
sensitive to the effects of UV radiation in that squamous papillomas
develop following exposure, some of which progress to SCC and SCT.
Although in this study the Tg.AC mice did not show evidence of p53
mutations, which is thought to be an essential event in UVR-
tumorigenesis in both humans and mice, we can explain these results
due to differences in the exposure regimen employed. We did find,
however, that the mouse responds in a predicted fashion to acute
UVR exposure with respect to upregulation of p53 expression. There
was no evidence of actinic keratosis, which are common premalignant
lesions seen in humans and in some mouse models, but rather a rapid
papilloma response developed. This is at variance with other mouse
models, but could also be explained by the acute nature of the UVR
exposure protocol, which resulted in rapid activation of the ras
transgene, with consequent transgene-mediated proliferation and papil-
loma development consistent with what is observed following chemical
exposure and full-thickness wounding. Because there is a rapid tumor
response to UVR under acute exposure conditions, the model is
valuable for studying molecular mechanisms of photocarcinogenesis
not involving the p53 tumor suppressor gene. It may also be valuable
as a tool for chemical and/or product testing as the rapid photoinduction
of papillomas can be used as a reporter phenotype. The low background
of spontaneous tumors and rapid inducibility of the phenotype can
provide a model to evaluate substances that may enhance or block
UVR-induced tumors.
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